3.11
+0.08(+2.64%)
Currency In USD
| Previous Close | 3.03 |
| Open | 3.11 |
| Day High | 3.11 |
| Day Low | 3.03 |
| 52-Week High | 29.45 |
| 52-Week Low | 2.96 |
| Volume | 10,475 |
| Average Volume | 49,764 |
| Market Cap | 2.29M |
| PE | 0 |
| EPS | 3,635 |
| Moving Average 50 Days | 3.61 |
| Moving Average 200 Days | 7.32 |
| Change | 0.08 |
If you invested $1000 in Qualigen Therapeutics, Inc. (QLGN) since IPO date, it would be worth $0 as of March 14, 2025 at a share price of $3.11. Whereas If you bought $1000 worth of Qualigen Therapeutics, Inc. (QLGN) shares 5 years ago, it would be worth $1.22 as of March 14, 2025 at a share price of $3.11.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Qualigen to participate in next funding round for NanoSynex
GlobeNewswire Inc.
Jan 28, 2025 1:00 PM GMT
Market size expected to reach $4.7 billion in 2027 CARLSBAD, Calif., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”)announced today they will be the first investors participating in the 2025 bridge round
Qualigen Therapeutics Announces Regained Compliance with Nasdaq's Minimum Bid Price Requirement and the Equity Requirement
GlobeNewswire Inc.
Dec 05, 2024 2:00 PM GMT
Carlsbad, CA, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Qualigen Therapeutics (NASDAQ: QLGN) (the “Company” or “Qualigen”) today announced that the Company received formal notice from The Nasdaq Stock Market LLC (“Nasdaq”) that the Company has regained com
Qualigen Therapeutics Announces $4.5 Million Private Placement of Convertible Preferred Shares
GlobeNewswire Inc.
Nov 19, 2024 2:00 PM GMT
Carlsbad, CA, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ:QLGN) ("Qualigen" or the "Company"), Qualigen Therapeutics, Inc., is a life science company focused on developing platform treatments for adult and pediatric cancer